SFX by Ex Libris Inc.

Title:	The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome
Source:	International Journal of Cancer [0020-7136] Habermann, Jens yr:2009

Basic

Full text

Full text available via Wiley Online Library All Journals

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library STM 2011

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Desmedt, C. "Gene expression predictors in breast cancer: current status, limitations and perspectives." European journal of cancer 44.18 (2008): 2714-20.
description	2.	Odze, Robert D D. "DNA ploidy abnormalities in basal and superficial regions of the crypts in Barrett's esophagus and associated neoplastic lesions." The American journal of surgical pathology 32.9 (2008): 1327-35.
description	3.	Mina, L. "Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue." Breast cancer research and treatment 103.2 (2007): 197-208.
description	4.	Wu, J. "Distribution patterns of 21-gene recurrence score in 980 Chinese estrogen receptor-positive, HER2-negative early breast cancer patients." Oncotarget. 8.24: 38706-38716.
description	5.	"Test May Help Breast Cancer Fight." Wall Street Journal - Eastern Edition 244.115 (2004).
description	6.	Chang, Jenny C. "Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients." Breast Cancer Research and Treatment 108.2 (2008): 233-240.
description	7.	Berry, J Michael M. "Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia." Diseases of the colon & rectum 52.2 (2009): 239-47.
description	8.	Bonnefoi, H. "Predictive signatures for chemotherapy sensitivity in breast cancer: Are they ready for use in the clinic?" European journal of cancer 45.10 (2009): 1733-1743.
description	9.	synergy@blackwell-synergy.com (Delphine Janisson-D, D. "Aneuploidy, but not Ki-67 or EGFR expression, is associated with recurrences in basal cell carcinoma." Journal of cutaneous pathology 35.10 (2008): 916-21.
description	10.	Isabel T. Rubio, I T. "Use of genome typing in breast cancer." Journal of surgical oncology 99.1 (2008): 3-4.
description	11.	Gomez-Millan, J. "Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells." International journal of radiation oncology, biology, physics 67.3 (2007): 897-905.
description	12.	Paik S, S. "Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer." Journal of clinical oncology 24.23 (2006): 3726-34.
description	13.	Albain, Kathy S. "Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial." The lancet oncology 11.1 (2009): 55-65.
description	14.	Hochreiter, Amelia E E. "Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer." Clinical cancer research 12.10 (2006): 3184-3192.
description	15.	Ferraris, A. "Anal pap smear in high-risk patients: a poor screening tool." Southern medical journal 101.11 (2008): 1185-6.
description	16.	Fisher, B. "Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer." Journal of the National Cancer Institute 89.22 (1997): 1673-82.
description	17.	Wieland, U. "Human papillomavirus-associated diseases in HIV-infected men who have sex with men." Current opinion in infectious diseases 22.2 (2009): 109-14.
description	18.	"Cross-stratification and differential risk by breast cancer index and recurrence score in women with hormone receptor-positive lymph node-negative early-stage breast cancer." Clinical cancer research. 22.20: 5043-.
description	19.	Roberts, Megan C. "Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database." Breast cancer research and treatment 163.2: 303-310.
description	20.	Olszewska, M. "Positioning of chromosome 15, 18, X and Y centromeres in sperm cells of fertile individuals and infertile patients with increased level of aneuploidy." Chromosome research 16.6 (2008): 875-890.